Resmed Inc
NYSE:RMD
Resmed Inc
Income from Continuing Operations
Resmed Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Resmed Inc
NYSE:RMD
|
Income from Continuing Operations
$958.4m
|
CAGR 3-Years
28%
|
CAGR 5-Years
16%
|
CAGR 10-Years
11%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$1.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Resmed Inc's Income from Continuing Operations?
Income from Continuing Operations
958.4m
USD
Based on the financial report for Mar 31, 2024, Resmed Inc's Income from Continuing Operations amounts to 958.4m USD.
What is Resmed Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
11%
Over the last year, the Income from Continuing Operations growth was 11%. The average annual Income from Continuing Operations growth rates for Resmed Inc have been 28% over the past three years , 16% over the past five years , and 11% over the past ten years .